News Establishment Labs Holdings Inc.

Equities

ESTA

VGG312491084

Real-time Estimate Cboe BZX Other stock markets 11:51:32 2024-06-10 am EDT			5-day change	1st Jan Change
48.42 ^USD	+0.63%		-4.75%	+90.65%

02:00pm	Transcript : Establishment Labs Holdings Inc. Presents at Goldman Sachs 45th Annual Global Healthcare Conference, Jun-10-2024 08:00 AM
Jun. 06	Mizuho Securities Raises Price Target on Establishment Labs to $70 From $65, Maintains Buy Rating	MT

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Transcript : Establishment Labs Holdings Inc. Presents at Goldman Sachs 45th Annual Global Healthcare Conference, Jun-10-2024 08:00 AM	08:00am
Mizuho Securities Raises Price Target on Establishment Labs to $70 From $65, Maintains Buy Rating	Jun. 06	MT
Establishment Labs Announces Participation in Two Upcoming Investment Conferences	May. 23	BU
Citigroup Downgrades Establishment Labs Holdings to Neutral From Buy With $60 Price Target	May. 22	MT
Transcript : Establishment Labs Holdings Inc., Q1 2024 Earnings Call, May 08, 2024	May. 08
Establishment Labs Holdings Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	May. 08	CI
Earnings Flash (ESTA) ESTABLISHMENT LABS HOLDINGS Posts Q1 Revenue $37.2M, vs. Street Est of $35.5M	May. 08	MT
Establishment Labs Reports First Quarter 2024 Financial Results	May. 08	BU
Establishment Labs Holdings Inc. Provides Revenue Guidance for the Year 2024	May. 08	CI
Establishment Labs Notes Presentation of 4-Year Results from Motiva U.S. IDE Study at The Aesthetic Meeting 2024	May. 02	BU
Establishment Labs Announces Appointment of Jeff Ehrhardt as General Manager of North America	May. 01	BU
Establishment Labs to Announce First Quarter 2024 Financial Results on May 8	Apr. 24	BU
Establishment Labs Announces Participation in The Aesthetic Meeting 2024	Apr. 17	BU
Citigroup Raises Price Target on Establishment Labs to $60 From $49, Maintains Buy Rating	Apr. 03	MT
Establishment Labs Says US FDA Schedules Preapproval Inspection of Motiva Implants Facility	Apr. 02	MT
Mizuho Securities Raiset Price Target on Establishment Labs to $65 From $50, Keeps Buy Rating	Apr. 01	MT
TD Cowen Adjusts Establishment Labs Price Target to $60 From $50, Maintains Outperform Rating	Mar. 12	MT
Transcript : Establishment Labs Holdings Inc. Presents at Citi?s 2024 Unplugged Medtech and Life Sciences Access Day, Feb-29-2024 02:30 PM	Feb. 29
Transcript : Establishment Labs Holdings Inc., Q4 2023 Earnings Call, Feb 28, 2024	Feb. 28
Establishment Labs Holdings Inc. Provides Revenue Guidance for the Year 2024	Feb. 28	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Establishment Labs Holdings Inc.

Equities

ESTA

VGG312491084

Summary

Filters